Tuva Health vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 30)
Tuva Health logo

Tuva Health

EmergingHealthcare

General

NY open-source healthcare claims data transformation platform serving 1,500+ practitioners at Oscar Health and MultiCare; YC W22 $6M Virtue-backed first health system-backed open-source data platform competing with Datavant for healthcare analytics engineering.

AI VisibilityBeta
Overall Score
D30
Category Rank
#812 of 1158
AI Consensus
58%
Trend
up
Per Platform
ChatGPT
25
Perplexity
21
Gemini
39

About

Tuva Health is a New York-based open-source healthcare data transformation company — backed by Y Combinator (W22) with $6 million raised including a $5 million seed round in December 2024 led by Virtue with Box Group, YC, and health technology angels, plus MultiCare Capital Partners (investment from MultiCare Health System making Tuva the first open-source data platform backed by a health system) in February 2025 — operating the Tuva Project, the world's first open-source healthcare data transformation platform that enables payers, providers, and pharmaceutical companies to convert raw claims and EHR datasets into analytics-ready data models through built-in normalization, quality testing, and clinical enrichment. Tuva serves 1,500+ healthcare data practitioners and 30+ partners including Oscar Health and MultiCare.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

30
Overall Score
94
#812
Category Rank
#19
58
AI Consensus
71
up
Trend
stable
25
ChatGPT
99
21
Perplexity
92
39
Gemini
88
27
Claude
94
32
Grok
99

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.